STEPHANIE CASSADY: Open Payments
NPI 1376541367 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 23 payments from 11 companies in 2025. Trend: 2023 $390 · 2024 $334 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| ABBVIE INC. | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| Boston Scientific Corporation | 3 | $54 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Lilly USA, LLC | 2 | $41 |
| Eisai Inc. | 1 | $34 |
| Amgen Inc. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: VRAYLAR, LEQVIO, General - Therapies, MOUNJARO, Rybelsus, Leqembi, OTEZLA, SHINGRIX.
Industry payments across FL — which companies pay providers there.
